As previously described, ITD-positive AML cells depend on efficient protein degradation mechanisms, including the USP14/UCHL5-mediated degradation of large amounts of intracellular proteins in the UPS and antioxidant regulation (Figure 5). The gene discussed is UCHL5; the disease is acute myeloid leukemia.